Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 17Colorectal Neoplasms 14Neoplasms 13Carcinoma, Hepatocellular 11Prostatic Neoplasms 7Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Stomach Neoplasms 5Anastomotic Leak 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Multiple Myeloma 4Lymphoma, Follicular 4Disease 4Stomatitis 3Recurrence 3Pancreatic Neoplasms 3Myeloproliferative Disorders 3Lymphoma 3HIV Infections 3Depression 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Vulvar Neoplasms 2Surgical Wound Infection 2Sleep Initiation and Maintenance Disorders 2Sarcoma 2Postoperative Complications 2Pilonidal Sinus 2

Interventions

Vitamin D 1Synbiotics 1Prebiotics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Chemotherapy-Related Cognitive Impairment × 90 days × Clear all
NCT07465497 2026-03-12

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Instituto Jalisciense de Cancerologia

Phase NA Enrolling by invitation
80 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡